We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

EPICENTRE Launches TransforMax™ EC100™ Competent E. Coli Cells

Listen with
Speechify
0:00
Register for free to listen to this article
Thank you. Listen to this article using the player above.

Want to listen to this article for FREE?

Complete the form below to unlock access to ALL audio articles.

Read time: Less than a minute

EPICENTRE’s has introduced TransforMax™ EC100™ Electrocompetent E. coli and TransforMax™ EC100™ Chemically Competent E. coli competent cells for most cloning applications.

According to Company, the benefits include high transformation efficiencies: >1 x 1010 cfu/µg and >1 x 108 cfu/µg of pUC19 with the electrocompetent and chemically competent cells, respectively; the ability to accept large DNAs for construction of large-insert genomic libraries, and the genotype lac Z?M15 for blue/white screening of recombinants.

The cells are also genotypically endonuclease minus (endA1) and recombination minus (recA1) to ensure high yields of DNA and the greater stability of large cloned inserts.